# BriaCell Therapeutics Corp.: Form 6-K, filed Jul 18, 2022

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 6-K
- Filed: 2022-07-18
- Accepted by EDGAR: Jul 18, 2022, 07:27 ET
- Period: 2022-07-18
- Accession: 0001493152-22-019531
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315222019531/form6-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315222019531/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315222019531/form6-k.htm

Filed Jul 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-019531. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
